The US faces its worst flu season in 15 years amid bird flu spread and unprecedented disruptions to federal public health systems.

The FTC confirms PBMs are price-gouging specialty generics, raking in billions while blocking patient access to life-saving meds.

Congress faces urgent healthcare decisions before 2025—telehealth, CHC funding, and physician payments hang in the balance during lame duck.

New CDC data shows first significant declines in STI and overdose rates, but funding cuts and systemic barriers threaten sustained progress.